nodes	percent_of_prediction	percent_of_DWPC	metapath
Sufentanil—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.183	0.282	CbGbCtD
Sufentanil—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.124	0.19	CbGbCtD
Sufentanil—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.118	0.182	CbGbCtD
Sufentanil—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.105	0.162	CbGbCtD
Sufentanil—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0618	0.095	CbGbCtD
Sufentanil—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0584	0.0897	CbGbCtD
Sufentanil—Respiratory depression—Aminophylline—chronic obstructive pulmonary disease	0.0106	0.0348	CcSEcCtD
Sufentanil—Pulmonary function test decreased—Aminophylline—chronic obstructive pulmonary disease	0.0106	0.0348	CcSEcCtD
Sufentanil—Injection site pain—Formoterol—chronic obstructive pulmonary disease	0.00747	0.0244	CcSEcCtD
Sufentanil—Injection site pain—Arformoterol—chronic obstructive pulmonary disease	0.00747	0.0244	CcSEcCtD
Sufentanil—Urinary retention—Aminophylline—chronic obstructive pulmonary disease	0.00553	0.0181	CcSEcCtD
Sufentanil—Urinary retention—Tiotropium—chronic obstructive pulmonary disease	0.00522	0.0171	CcSEcCtD
Sufentanil—Euphoric mood—Salbutamol—chronic obstructive pulmonary disease	0.00495	0.0162	CcSEcCtD
Sufentanil—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.00376	0.0123	CcSEcCtD
Sufentanil—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.00376	0.0123	CcSEcCtD
Sufentanil—Urinary tract disorder—Tiotropium—chronic obstructive pulmonary disease	0.00375	0.0123	CcSEcCtD
Sufentanil—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.00372	0.0122	CcSEcCtD
Sufentanil—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.0036	0.0118	CcSEcCtD
Sufentanil—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.00355	0.0116	CcSEcCtD
Sufentanil—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00353	0.0116	CcSEcCtD
Sufentanil—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.00339	0.0111	CcSEcCtD
Sufentanil—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00316	0.0103	CcSEcCtD
Sufentanil—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00314	0.0749	CbGpPWpGaD
Sufentanil—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.00303	0.00989	CcSEcCtD
Sufentanil—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.00303	0.00989	CcSEcCtD
Sufentanil—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.003	0.00982	CcSEcCtD
Sufentanil—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.003	0.00982	CcSEcCtD
Sufentanil—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.00296	0.00969	CcSEcCtD
Sufentanil—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.00294	0.00961	CcSEcCtD
Sufentanil—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00286	0.00935	CcSEcCtD
Sufentanil—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.00286	0.00934	CcSEcCtD
Sufentanil—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00285	0.00933	CcSEcCtD
Sufentanil—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.00284	0.00928	CcSEcCtD
Sufentanil—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00284	0.00927	CcSEcCtD
Sufentanil—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.00284	0.00927	CcSEcCtD
Sufentanil—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00279	0.00912	CcSEcCtD
Sufentanil—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00277	0.0662	CbGpPWpGaD
Sufentanil—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.00274	0.00895	CcSEcCtD
Sufentanil—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.00274	0.00895	CcSEcCtD
Sufentanil—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00273	0.00891	CcSEcCtD
Sufentanil—Rash—Roflumilast—chronic obstructive pulmonary disease	0.0027	0.00884	CcSEcCtD
Sufentanil—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.0027	0.00883	CcSEcCtD
Sufentanil—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00269	0.00878	CcSEcCtD
Sufentanil—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00267	0.00873	CcSEcCtD
Sufentanil—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00263	0.0086	CcSEcCtD
Sufentanil—Chills—Salbutamol—chronic obstructive pulmonary disease	0.0026	0.00848	CcSEcCtD
Sufentanil—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00258	0.00845	CcSEcCtD
Sufentanil—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00255	0.00833	CcSEcCtD
Sufentanil—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.0023	0.00753	CcSEcCtD
Sufentanil—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.0023	0.00753	CcSEcCtD
Sufentanil—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.00228	0.00745	CcSEcCtD
Sufentanil—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00227	0.0541	CbGpPWpGaD
Sufentanil—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00226	0.00739	CcSEcCtD
Sufentanil—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00218	0.00711	CcSEcCtD
Sufentanil—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00218	0.00711	CcSEcCtD
Sufentanil—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00217	0.00711	CcSEcCtD
Sufentanil—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00213	0.00697	CcSEcCtD
Sufentanil—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00212	0.00694	CcSEcCtD
Sufentanil—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00212	0.00694	CcSEcCtD
Sufentanil—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00211	0.00689	CcSEcCtD
Sufentanil—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.00206	0.00674	CcSEcCtD
Sufentanil—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00206	0.00672	CcSEcCtD
Sufentanil—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00203	0.00665	CcSEcCtD
Sufentanil—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00203	0.00665	CcSEcCtD
Sufentanil—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00202	0.00661	CcSEcCtD
Sufentanil—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00201	0.00656	CcSEcCtD
Sufentanil—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00199	0.00649	CcSEcCtD
Sufentanil—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00193	0.00632	CcSEcCtD
Sufentanil—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00193	0.00632	CcSEcCtD
Sufentanil—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00192	0.00628	CcSEcCtD
Sufentanil—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00191	0.00624	CcSEcCtD
Sufentanil—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.0019	0.00619	CcSEcCtD
Sufentanil—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00189	0.00618	CcSEcCtD
Sufentanil—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00183	0.00597	CcSEcCtD
Sufentanil—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00182	0.00594	CcSEcCtD
Sufentanil—Rash—Aminophylline—chronic obstructive pulmonary disease	0.0018	0.00589	CcSEcCtD
Sufentanil—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.0018	0.00589	CcSEcCtD
Sufentanil—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00179	0.00586	CcSEcCtD
Sufentanil—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00179	0.00586	CcSEcCtD
Sufentanil—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00179	0.00586	CcSEcCtD
Sufentanil—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00178	0.00583	CcSEcCtD
Sufentanil—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00172	0.00562	CcSEcCtD
Sufentanil—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00172	0.00562	CcSEcCtD
Sufentanil—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00171	0.0056	CcSEcCtD
Sufentanil—Rash—Tiotropium—chronic obstructive pulmonary disease	0.0017	0.00556	CcSEcCtD
Sufentanil—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.0017	0.00555	CcSEcCtD
Sufentanil—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.0017	0.00555	CcSEcCtD
Sufentanil—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00169	0.00554	CcSEcCtD
Sufentanil—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00169	0.00552	CcSEcCtD
Sufentanil—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00169	0.00552	CcSEcCtD
Sufentanil—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00169	0.00551	CcSEcCtD
Sufentanil—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.00166	0.00542	CcSEcCtD
Sufentanil—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00162	0.00531	CcSEcCtD
Sufentanil—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.0016	0.00524	CcSEcCtD
Sufentanil—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.0016	0.00524	CcSEcCtD
Sufentanil—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.0016	0.00524	CcSEcCtD
Sufentanil—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00157	0.00513	CcSEcCtD
Sufentanil—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00154	0.00503	CcSEcCtD
Sufentanil—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00154	0.00503	CcSEcCtD
Sufentanil—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00151	0.00495	CcSEcCtD
Sufentanil—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00151	0.00493	CcSEcCtD
Sufentanil—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00148	0.00484	CcSEcCtD
Sufentanil—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00475	CcSEcCtD
Sufentanil—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00144	0.00472	CcSEcCtD
Sufentanil—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00144	0.0047	CcSEcCtD
Sufentanil—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00144	0.0047	CcSEcCtD
Sufentanil—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00141	0.00461	CcSEcCtD
Sufentanil—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00138	0.00452	CcSEcCtD
Sufentanil—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00138	0.00452	CcSEcCtD
Sufentanil—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.00449	CcSEcCtD
Sufentanil—Rash—Formoterol—chronic obstructive pulmonary disease	0.00137	0.00449	CcSEcCtD
Sufentanil—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00137	0.00448	CcSEcCtD
Sufentanil—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.00448	CcSEcCtD
Sufentanil—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00136	0.00446	CcSEcCtD
Sufentanil—Headache—Formoterol—chronic obstructive pulmonary disease	0.00136	0.00446	CcSEcCtD
Sufentanil—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00136	0.00444	CcSEcCtD
Sufentanil—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00136	0.00443	CcSEcCtD
Sufentanil—Rash—Montelukast—chronic obstructive pulmonary disease	0.00134	0.00439	CcSEcCtD
Sufentanil—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00134	0.00439	CcSEcCtD
Sufentanil—Headache—Montelukast—chronic obstructive pulmonary disease	0.00134	0.00437	CcSEcCtD
Sufentanil—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.00427	CcSEcCtD
Sufentanil—Rash—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.00424	CcSEcCtD
Sufentanil—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00423	CcSEcCtD
Sufentanil—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00129	0.00423	CcSEcCtD
Sufentanil—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00129	0.00423	CcSEcCtD
Sufentanil—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00421	CcSEcCtD
Sufentanil—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00127	0.00414	CcSEcCtD
Sufentanil—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00125	0.00408	CcSEcCtD
Sufentanil—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00123	0.00401	CcSEcCtD
Sufentanil—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00122	0.00399	CcSEcCtD
Sufentanil—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00118	0.00385	CcSEcCtD
Sufentanil—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00115	0.0275	CbGpPWpGaD
Sufentanil—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00115	0.00376	CcSEcCtD
Sufentanil—Alfentanil—ALB—chronic obstructive pulmonary disease	0.00115	1	CrCbGaD
Sufentanil—OPRD1—Peptide GPCRs—CXCR2—chronic obstructive pulmonary disease	0.00113	0.0269	CbGpPWpGaD
Sufentanil—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.00108	0.00352	CcSEcCtD
Sufentanil—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00105	0.00343	CcSEcCtD
Sufentanil—OPRK1—Peptide GPCRs—CXCR2—chronic obstructive pulmonary disease	0.000989	0.0236	CbGpPWpGaD
Sufentanil—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000971	0.00318	CcSEcCtD
Sufentanil—OPRM1—Opioid Signalling—PDE4A—chronic obstructive pulmonary disease	0.000964	0.023	CbGpPWpGaD
Sufentanil—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000906	0.00296	CcSEcCtD
Sufentanil—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000883	0.0211	CbGpPWpGaD
Sufentanil—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000868	0.00284	CcSEcCtD
Sufentanil—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000857	0.0028	CcSEcCtD
Sufentanil—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000836	0.00273	CcSEcCtD
Sufentanil—OPRM1—Peptide GPCRs—CXCR2—chronic obstructive pulmonary disease	0.000836	0.0199	CbGpPWpGaD
Sufentanil—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000779	0.00255	CcSEcCtD
Sufentanil—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000743	0.00243	CcSEcCtD
Sufentanil—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000743	0.00243	CcSEcCtD
Sufentanil—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000738	0.00241	CcSEcCtD
Sufentanil—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000706	0.00231	CcSEcCtD
Sufentanil—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.0007	0.00229	CcSEcCtD
Sufentanil—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000684	0.0163	CbGpPWpGaD
Sufentanil—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000677	0.00221	CcSEcCtD
Sufentanil—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000631	0.00206	CcSEcCtD
Sufentanil—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000606	0.00198	CcSEcCtD
Sufentanil—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000595	0.0142	CbGpPWpGaD
Sufentanil—OPRM1—TCR Signaling Pathway—IL17A—chronic obstructive pulmonary disease	0.000582	0.0139	CbGpPWpGaD
Sufentanil—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000566	0.00185	CcSEcCtD
Sufentanil—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000545	0.00178	CcSEcCtD
Sufentanil—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000541	0.0129	CbGpPWpGaD
Sufentanil—Rash—Prednisone—chronic obstructive pulmonary disease	0.00054	0.00177	CcSEcCtD
Sufentanil—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00054	0.00176	CcSEcCtD
Sufentanil—Headache—Prednisone—chronic obstructive pulmonary disease	0.000537	0.00175	CcSEcCtD
Sufentanil—OPRM1—IL4-mediated signaling events—IL10—chronic obstructive pulmonary disease	0.000533	0.0127	CbGpPWpGaD
Sufentanil—OPRD1—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.00053	0.0127	CbGpPWpGaD
Sufentanil—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000518	0.0124	CbGpPWpGaD
Sufentanil—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000509	0.00166	CcSEcCtD
Sufentanil—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000497	0.0119	CbGpPWpGaD
Sufentanil—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000478	0.0114	CbGpPWpGaD
Sufentanil—OPRK1—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.000465	0.0111	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000447	0.0107	CbGpPWpGaD
Sufentanil—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000432	0.0103	CbGpPWpGaD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000415	0.0099	CbGpPWpGaD
Sufentanil—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000415	0.00989	CbGpPWpGaD
Sufentanil—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000393	0.00938	CbGpPWpGaD
Sufentanil—OPRM1—Peptide ligand-binding receptors—CXCR2—chronic obstructive pulmonary disease	0.000393	0.00938	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000392	0.00936	CbGpPWpGaD
Sufentanil—OPRM1—TCR Signaling Pathway—CD8A—chronic obstructive pulmonary disease	0.000391	0.00934	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000364	0.00869	CbGpPWpGaD
Sufentanil—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000361	0.00862	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000356	0.00849	CbGpPWpGaD
Sufentanil—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000348	0.00829	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000332	0.00791	CbGpPWpGaD
Sufentanil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000325	0.00776	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000312	0.00744	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000308	0.00734	CbGpPWpGaD
Sufentanil—OPRD1—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.000297	0.00709	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000271	0.00646	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000264	0.00629	CbGpPWpGaD
Sufentanil—OPRK1—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.000261	0.00622	CbGpPWpGaD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.00026	0.00621	CbGpPWpGaD
Sufentanil—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000255	0.00609	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000238	0.00567	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000228	0.00545	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000223	0.00532	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000222	0.00529	CbGpPWpGaD
Sufentanil—OPRM1—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.00022	0.00526	CbGpPWpGaD
Sufentanil—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000211	0.00504	CbGpPWpGaD
Sufentanil—OPRM1—TCR Signaling Pathway—IL1B—chronic obstructive pulmonary disease	0.000208	0.00495	CbGpPWpGaD
Sufentanil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000207	0.00493	CbGpPWpGaD
Sufentanil—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000204	0.00486	CbGpPWpGaD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000204	0.00486	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000201	0.00479	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000199	0.00476	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000196	0.00467	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000195	0.00464	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000193	0.0046	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.00019	0.00453	CbGpPWpGaD
Sufentanil—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000186	0.00443	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000179	0.00426	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000175	0.00417	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000174	0.00416	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000172	0.00411	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.00017	0.00405	CbGpPWpGaD
Sufentanil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000167	0.00399	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000167	0.00397	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000165	0.00395	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000164	0.00392	CbGpPWpGaD
Sufentanil—OPRM1—TCR Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	0.000161	0.00385	CbGpPWpGaD
Sufentanil—OPRD1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000161	0.00383	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000153	0.00365	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000153	0.00365	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000152	0.00362	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000151	0.00361	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000151	0.0036	CbGpPWpGaD
Sufentanil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00015	0.00358	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000149	0.00355	CbGpPWpGaD
Sufentanil—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000148	0.00353	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000148	0.00353	CbGpPWpGaD
Sufentanil—OPRK1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000141	0.00336	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000141	0.00336	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000139	0.00332	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000136	0.00323	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000134	0.00321	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000134	0.0032	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000133	0.00318	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000133	0.00317	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000129	0.00308	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000128	0.00305	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000126	0.003	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000122	0.00291	CbGpPWpGaD
Sufentanil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000122	0.0029	CbGpPWpGaD
Sufentanil—OPRM1—TCR Signaling Pathway—IL6—chronic obstructive pulmonary disease	0.000122	0.0029	CbGpPWpGaD
Sufentanil—OPRM1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000119	0.00284	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000119	0.00284	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000118	0.00281	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000116	0.00278	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000113	0.00271	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000113	0.00268	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000108	0.00257	CbGpPWpGaD
Sufentanil—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000107	0.00255	CbGpPWpGaD
Sufentanil—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000106	0.00252	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000103	0.00246	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000102	0.00243	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.0001	0.0024	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	9.96e-05	0.00238	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	9.84e-05	0.00235	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	9.6e-05	0.00229	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	9.45e-05	0.00225	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	8.93e-05	0.00213	CbGpPWpGaD
Sufentanil—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.89e-05	0.00212	CbGpPWpGaD
Sufentanil—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.77e-05	0.00209	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	8.72e-05	0.00208	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	8.58e-05	0.00205	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	8.42e-05	0.00201	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	8.21e-05	0.00196	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	8.21e-05	0.00196	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	7.99e-05	0.00191	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	7.79e-05	0.00186	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	7.65e-05	0.00182	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	7.55e-05	0.0018	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	7.52e-05	0.0018	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	7.51e-05	0.00179	CbGpPWpGaD
Sufentanil—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.42e-05	0.00177	CbGpPWpGaD
Sufentanil—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.32e-05	0.00175	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	7.2e-05	0.00172	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	7.2e-05	0.00172	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	7.12e-05	0.0017	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	6.83e-05	0.00163	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	6.82e-05	0.00163	CbGpPWpGaD
Sufentanil—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.82e-05	0.00163	CbGpPWpGaD
Sufentanil—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.72e-05	0.0016	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	6.58e-05	0.00157	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	6.46e-05	0.00154	CbGpPWpGaD
Sufentanil—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.46e-05	0.00154	CbGpPWpGaD
Sufentanil—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.37e-05	0.00152	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	6.36e-05	0.00152	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	6.09e-05	0.00145	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	6.08e-05	0.00145	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6e-05	0.00143	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	5.98e-05	0.00143	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.78e-05	0.00138	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.58e-05	0.00133	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.56e-05	0.00133	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.26e-05	0.00126	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	5.2e-05	0.00124	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.15e-05	0.00123	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	5.05e-05	0.00121	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.89e-05	0.00117	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.64e-05	0.00111	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.6e-05	0.0011	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.52e-05	0.00108	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.45e-05	0.00106	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.21e-05	0.001	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.18e-05	0.000998	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.14e-05	0.000987	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.07e-05	0.00097	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.04e-05	0.000963	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.03e-05	0.000961	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.82e-05	0.000911	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.74e-05	0.000893	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.69e-05	0.000881	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.67e-05	0.000875	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.53e-05	0.000842	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.44e-05	0.000821	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.44e-05	0.00082	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.41e-05	0.000814	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	3.35e-05	0.000799	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.28e-05	0.000783	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.12e-05	0.000745	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.11e-05	0.000743	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.1e-05	0.00074	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.08e-05	0.000734	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.98e-05	0.000712	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.94e-05	0.000701	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.8e-05	0.000669	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.77e-05	0.000662	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.7e-05	0.000644	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.58e-05	0.000615	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.49e-05	0.000594	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.46e-05	0.000587	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.37e-05	0.000564	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.28e-05	0.000544	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.25e-05	0.000537	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.18e-05	0.00052	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.18e-05	0.000519	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.08e-05	0.000496	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.07e-05	0.000495	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.02e-05	0.000482	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.97e-05	0.000471	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.85e-05	0.000442	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.84e-05	0.00044	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.83e-05	0.000437	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.82e-05	0.000434	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.81e-05	0.000432	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.77e-05	0.000423	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.75e-05	0.000418	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.67e-05	0.000398	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.65e-05	0.000394	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.63e-05	0.000388	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.59e-05	0.00038	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.53e-05	0.000364	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.52e-05	0.000363	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.5e-05	0.000357	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.4e-05	0.000333	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.37e-05	0.000328	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.35e-05	0.000322	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.34e-05	0.000319	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.27e-05	0.000303	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.25e-05	0.000298	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.23e-05	0.000292	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.17e-05	0.000278	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.13e-05	0.00027	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.1e-05	0.000264	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.04e-05	0.000247	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	7.51e-06	0.000179	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	7.18e-06	0.000171	CbGpPWpGaD
